Skip to main content
Clinical Trials/CTRI/2020/07/026602
CTRI/2020/07/026602
Not yet recruiting
Phase 2

A prospective non-randomized interventional study to determine the efficacy of an Ayurveda regimen in COVID Positive patients

Deenanath Mangeshkar Hospital Research Centre0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Deenanath Mangeshkar Hospital Research Centre
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Deenanath Mangeshkar Hospital Research Centre

Eligibility Criteria

Inclusion Criteria

  • Patients admitting to IPD of DMHRC; with Mild\-Moderate symptoms as per DMER Guidelines (Group B category Fever, Cough, Running nose, without shortness of breath,RR \<24/min). Patients with known case of Daibetes Mellitus on OHA, HT \& Asthma will be included.

Exclusion Criteria

  • Patients with co\-morbidities like COPD,IHD,CKD, Coagulopathy, Cancer will be excluded. Diabetic Patients taking Insulin will be excluded. Patients with Sr. Creatinine \>1\.5, Sr. Sodium \<128, Hb \<7\.0gm%, SPO2 \<90 will be excluded. Preganant\& Lactating mothers will be excluded. Patients who are on Immuno\-suppresants, Chemotherapy drugs will be excluded. By any reason / after any major Oral surgery etc, if patient is not able to swallow tablets will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials